|
1
|
Automated N-glycopeptide identification using a combination of single- and tandem-MS.
|
J Proteome Res
|
2007
|
1.22
|
|
2
|
Targeted glycoproteomic identification of cancer cell glycosylation.
|
Glycobiology
|
2009
|
1.02
|
|
3
|
Application of dried blood spots combined with HPLC-MS/MS for the quantification of acetaminophen in toxicokinetic studies.
|
J Chromatogr B Analyt Technol Biomed Life Sci
|
2008
|
0.99
|
|
4
|
Application of toxicokinetics to improve chemical risk assessment: implications for the use of animals.
|
Regul Toxicol Pharmacol
|
2009
|
0.82
|
|
5
|
Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease.
|
J Clin Invest
|
2015
|
0.81
|
|
6
|
Identification of novel contributions to high-affinity glycoprotein-receptor interactions using engineered ligands.
|
J Mol Biol
|
2009
|
0.81
|
|
7
|
Use of toxicokinetics to support chemical evaluation: Informing high dose selection and study interpretation.
|
Regul Toxicol Pharmacol
|
2011
|
0.79
|
|
8
|
N-Glycans on the link domain of human HARE/Stabilin-2 are needed for hyaluronan binding to purified ecto-domain, but not for cellular endocytosis of hyaluronan.
|
Glycobiology
|
2010
|
0.79
|
|
9
|
N-glycans and the N terminus of protein C inhibitor affect the cofactor-enhanced rates of thrombin inhibition.
|
J Biol Chem
|
2008
|
0.79
|
|
10
|
Mucin glycosylation and sulphation in airway epithelial cells is not influenced by cystic fibrosis transmembrane conductance regulator expression.
|
Am J Respir Cell Mol Biol
|
2005
|
0.78
|
|
11
|
Further insight into the roles of the glycans attached to human blood protein C inhibitor.
|
Biochem Biophys Res Commun
|
2010
|
0.77
|
|
12
|
In vivo glycosylation of MUC1 in airway epithelial cells.
|
Glycoconj J
|
2002
|
0.75
|